Arrowstreet Capital’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $120M | Buy |
|
|||||
|
2025
Q2 | $87.8M | Buy |
|
|||||
|
2025
Q1 | $53.2M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $17.7M | Sell |
|
|||||
|
2021
Q3 | $19.8M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $488K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $649K | Sell |
|
|||||
|
2019
Q2 | $24.8M | Buy |
|
|||||
|
2019
Q1 | $24.1M | Buy |
|
|||||
|
2018
Q4 | $6.94M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $11.2M | Sell |
|
|||||
|
2018
Q1 | $20.6M | Sell |
|
|||||
|
2017
Q4 | $46.5M | Buy |
|
|||||
|
2017
Q3 | $18.5M | Buy |
|
|||||
|
2017
Q2 | $344K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $4.72M | Buy |
|